160 related articles for article (PubMed ID: 11289309)
1. Molecular genetic analysis of the calcineurin signaling pathways.
Sugiura R; Sio SO; Shuntoh H; Kuno T
Cell Mol Life Sci; 2001 Feb; 58(2):278-88. PubMed ID: 11289309
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway.
Semsarian C; Wu MJ; Ju YK; Marciniec T; Yeoh T; Allen DG; Harvey RP; Graham RM
Nature; 1999 Aug; 400(6744):576-81. PubMed ID: 10448861
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin and beyond: cardiac hypertrophic signaling.
Molkentin JD
Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.
De Windt LJ; Lim HW; Haq S; Force T; Molkentin JD
J Biol Chem; 2000 May; 275(18):13571-9. PubMed ID: 10788473
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
7. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development.
Schulz RA; Yutzey KE
Dev Biol; 2004 Feb; 266(1):1-16. PubMed ID: 14729474
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure.
Haq S; Choukroun G; Lim H; Tymitz KM; del Monte F; Gwathmey J; Grazette L; Michael A; Hajjar R; Force T; Molkentin JD
Circulation; 2001 Feb; 103(5):670-7. PubMed ID: 11156878
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin anchoring and cell signaling.
Dodge KL; Scott JD
Biochem Biophys Res Commun; 2003 Nov; 311(4):1111-5. PubMed ID: 14623297
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MAPK signaling pathways through immunophilin-ligand complex.
Matsuda S; Koyasu S
Curr Top Med Chem; 2003; 3(12):1358-67. PubMed ID: 12871167
[TBL] [Abstract][Full Text] [Related]
13. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
14. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
15. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.
Liang Q; Bueno OF; Wilkins BJ; Kuan CY; Xia Y; Molkentin JD
EMBO J; 2003 Oct; 22(19):5079-89. PubMed ID: 14517246
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
18. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
[TBL] [Abstract][Full Text] [Related]
19. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy.
Parsons SA; Millay DP; Wilkins BJ; Bueno OF; Tsika GL; Neilson JR; Liberatore CM; Yutzey KE; Crabtree GR; Tsika RW; Molkentin JD
J Biol Chem; 2004 Jun; 279(25):26192-200. PubMed ID: 15082723
[TBL] [Abstract][Full Text] [Related]
20. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
